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Over 200 years ago, doctors’ most effective tools were typically not found in their medical bags. Indeed, most treatments in the history of medicine 
have, until relatively recently, caused more harm than good. Prior to the bio-
medical revolution in the late 19th century, doctors’ most reliable and effective 
instruments of healing were their skills of communication with patients and an 
aptitude for a positive and supportive bedside manner. Bearing out this portrait 
of medicine, Thomas Jefferson, writing in 1807, noted that “one of the most 
successful physicians I have ever known has assured me that he used more bread 
pills, drops of colored water, and powers of hickory ashes, than of all other medi-
cines put together” (qtd. in De Craen et al. 1999, 511). Jefferson referred to these 
skills of beneficent persuasion as a “pious fraud.” Exactly one hundred years later, 
in 1907, Mark Twain drew similar observations: “Physicians cure many patients 
with a bread pill; they know that where the disease is only a fancy, the patient’s 
confidence in the doctor will make the bread pill effective.”
Two major developments would downgrade the value of the interpersonal, 
doctor-patient relationship in professional medicine. The first development was 
the biomedical revolution. A wave of scientific medical success stories during 
the latter half of the 19th century would lead to a substantially more effective 
and reliable treatments and techniques than doctors had ever before employed. 
Encompassing a range of significant developments for public health and medical 
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care, the biomedical revolution included the emergence of the germ theory of 
disease, the use of anesthetics and antiseptics in surgery, and the development 
of vaccines. One consequence of these developments was the incorporation of 
determinedly scientific tools and training into biomedical education and clinical 
practice, with the result that the value of interpersonal, healing relationships be-
tween doctors and patients was devalued. In keeping with this idea, the Father 
of Modern Medicine, Canadian physician William Osler (1849–1919), acclaimed 
for putting medicine on a scientific footing and reforming medical education, 
taught that the temperament of the physician ought to be one of “detached 
concern.” Emphasizing the medical virtue of “Aequanimitas,” Osler placed a 
premium on scientific objectivity and a composed, steady, “clinical” demeanor 
in all patient interactions.
The second major development that indirectly devalued interpersonal doc-
tor-patient interactions occurred in the mid- to late-20th century: the emer-
gence of the randomized controlled trial (RCT). The goal of RCTs is to evaluate 
whether a drug or intervention is effective. Patients are randomly allocated to one 
of two groups: the “verum” or treatment that is under scrutiny, and a control 
group. The control group may receive no treatment or a placebo: the placebo 
is intended to serve as a yardstick; the goal is to eliminate all of the therapeutic 
“noise” that can arise when patients enroll in clinical trials, including any salubri-
ous effects of healing rituals, medical paraphernalia, or the positive effects of inter-
acting with health-care practitioners, as well as the natural progression of illness.
Even when the placebo pill or treatment is a sham, patients may experience 
health benefits from their participation in clinical trials. However, RCTs—the 
gold standard of clinical research—seek to determine whether the treatment un-
der scrutiny is effective over and above any positive effects of participating in 
trials, and of receiving placebo interventions. They therefore aim to eliminate 
the effects of human interactions, thus indirectly (and perhaps ironically) further 
discrediting, or at least distracting from, the potential therapeutic value of doc-
tor-patient interactions, including factors associated with the context of care.
However, somewhat paradoxically, RCTs have also helped identify the im-
portance of placebo effects in such a way as to make them a respectable subject 
for study. The same experimental design of the typical RCT, which is used to 
test for the effectiveness of an innovative treatment, can be likewise deployed to 
the comparison of a placebo and a no-treatment group. One goal associated with 
this research is to harness the significant medical effects of the social practices of 
doctor-patient interactions to improve patient outcomes.
This Special Section aims to take the marginalized factors relating to practi-
tioner-patient interactions out of the shadows of biomedicine and shine a spot-
light on them. How should we conceive of any positive (or indeed, negative) 
effects that arise not from biomedical interventions, but from the rituals of healing 
and from human interactions? The phenomenon that we have vaguely described, 
and intentionally avoided pinning down, is nowadays commonly referred to as 
“placebo effect(s)” (Evers et al. 2018). But this terminology is still the subject 
of debate and controversy: some scholars argue that the term “placebo effect” 
should be conserved; others contend that it is deeply problematic and should be 
revised or reconceived; still others propose that it should be dropped from med-
ical vocabulary altogether.
This Special Section focuses on one such proposal for reconceiving and rede-
fining placebo effects. Howard Brody (1980, 2000) and Daniel Moerman (2002; 
Moerman and Jonas 2002) both independently argue that “meaning models” or 
the “meaning response” help to explain the salubrious effects observed in both 
the typical practitioner-patient interaction as well as in control groups in clini-
cal trials. For example, Moerman proposes that the “meaning response” is “the 
psychological and physiological effects of meaning in the treatment of illness” 
(Moerman 2002, 14). On these distinctive frameworks, it is the meaning of treat-
ments and health-care interactions for patients that can give rise to significant 
therapeutic effects.
While the respective publications by Brody and by Moerman remain the most 
highly cited in the field of placebo studies, the term meaning is not universally 
preferred, and it has fallen out of favor among placebo researchers—even while 
debate still persists about how best to define “placebo effects.” Yet within other 
spheres of health-care research—for example, clinical psychology and narrative 
medicine—Moerman’s term “meaning response” is still extensively used as a 
term of art.
To date, however, there has been no systematic, scholarly evaluation of the 
terms “meaning model” and “meaning response.” This Special Section therefore 
aims to fulfill a neglected gap in health-care research by reflecting critically on the 
following themes: what might meaning mean in the realm of medicine and health 
care? Do such concepts add value to clinical research? Should we reconceive 
“placebo effects” via the concept of “meaning responses” or “meaning models”? 
And does the concept of meaning within patients’ health-care experiences ad-
vance our understanding of therapeutic processes in other domains, such as clin-
ical psychology? These—and other questions—are the central focus of this fresh 
reflection on Brody’s and Moerman’s work.
Most of the contributions in this collection emerged out of a multidisciplinary 
workshop hosted by Phil Hutchinson at Manchester Metropolitan University 
(MMU) in April 2016. The workshop (attended by Daniel Moerman) includ-
ed papers by philosophers and psychologists, aimed at reflecting, specifically, on 
Moerman’s concept of the “meaning response.” A second event—the inaugural 
conference of the Society for Interdisciplinary Placebo Studies—held at the Uni-
versity of Leiden in April 2017, strengthened the cross-disciplinary conversations 
that arose at that MMU workshop, directly leading to additional papers included 
within this collection. 
The Special Section opens with contributions from the pioneers in “meaning” 
in medicine. The collection begins with a new paper on the original mean-
ing model proposed by Howard Brody. This is followed by an article by Phil 
Hutchinson and Daniel Moerman, who weigh up three candidate explanations 
for “placebo responses”: classical conditioning, response expectancy, and Moer-
man’s own meaning response. Next is a “critical (and cautiously optimistic)” 
appraisal of Moerman’s meaning response theory by philosophers Marco Annoni 
and Charlotte Blease. The Special Section then includes a range of distinctive 
papers aimed at describing and evaluating the variety of conceptualizations of 
placebo effects in the literature. The first of these papers reviews the variety of 
frameworks proposed for placebo effects, emphasizing why psychoneurobiologi-
cal aspects of placebo phenomena provide a reliable tool in clinical practice. Next, 
a contribution by philosopher Andrew Turner proposes that any competing con-
ceptualizations of placebo effects (including meaning models and the meaning 
response) need to be held accountable to their potential practical value within 
medical research and practice. Finally, taking a different perspective, Charlotte 
Blease argues that conceptual disagreement in the field of placebo studies is over-
stated: drawing on insights from Thomas Kuhn, she argues that—appearances to 
the contrary—there is considerable underlying consensus about placebo concepts 
among researchers.
We thank the contributors for their stimulating contributions, and the Editors 
of Perspectives in Biology and Medicine for their excellent editorial guidance. We are 
confident that this Special Section will stimulate further cross-disciplinary discus-
sion and renewed debate on the meaning response, inspire deeper reflection on 
conceptual disputes in placebo studies, and encourage more discussion about the 
role of meaning within medicine and psychotherapy.
References
Brody, H. 1980. Placebos and the Philosophy of Medicine Clinical, Conceptual, and Ethical 
Issues. Chicago: University of Chicago Press.
Brody, H. 2000. “The Placebo Response: Recent Research and Implications for Family 
Medicine.” J Fam Pract 49: 649–54.
De Craen, A. J., et al. 1999. “Placebos and Placebo Effects in Medicine: Historical Over-
view.” J R Soc Med 92 (10): 511–15.
Evers, A. W. M., et al. 2018. “Implications of Placebo and Nocebo Effects for Clin-
ical Practice: Consensus of a Group of Experts.” Psychother Psychosom. DOI: 
10.1159/000490354.
Moerman, D. 2002. Meaning, Medicine, and the “Placebo Effect.” Cambridge: Cambridge 
University Press.
Moerman, D., and W. B. Jonas. 2002. “Deconstructing the Placebo Effect and Finding 
the Meaning Response.” Ann Intern Med 136 (6): 471–76.
Twain, M. 1907. Christian Science. N.p.: Hewlett Press, 2014.
